Dr. Manisha Patel is a tenured Professor in the Department of Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus and co-director of the University of Colorado Translational Epilepsy Program. Her research is focused on the role of metabolism in neuronal disorders including epilepsy. Her pioneering research demonstrated a role for superoxide radicals in excitotoxic cell death and its amelioration by a metalloporphyrin antioxidant. She is actively engaged in preclinical development of neuroprotective therapeutic entities such as metalloporphyrins designed to catalytically eliminate reactive oxygen species. She has received several awards such as the CURE Innovator Award, Shell Prize for Research and Graduate Education and American Epilepsy Society’s Distinguished Service Award. Dr. Patel serves on a number of editorial boards including Free Radical in Biology and Medicine, Epilepsia Open, Neurotoxicology and Redox Biology. She recently chaired the American Epilepsy Society’s Research and Training Council and has received numerous grants from the National Institutes of Health, CURE, Michael J. Fox Foundation and the Epilepsy Foundation of America.

Dr. Patel received her Bachelor of Pharmacy from the Maharaja Sayajirao University Faculty of Pharmacy, Ph.D. in Pharmacology and Toxicology at Purdue University and post-doctoral training in Neuroscience at Duke University.